hydrazine has been researched along with Vascular Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullen, ML; Chrissobolis, S; Drummond, GR; Hooker, EU; Kemp-Harper, BK; Ku, JM; Maxwell, KF; Michael De Silva, T; Miller, AA; Selemidis, S; Sobey, CG | 1 |
| Capettini, LS; Cruz, JS; Gioda, CR; Lemos, VS | 1 |
| CORCORAN, AC; MASSON, GM; PAGE, IH | 1 |
| FISHBEIN, M | 1 |
| SAMUELS, SS; SHAFTEL, HE | 1 |
| Tschudi-Steiner, I | 1 |
| Toth, B; Wilson, RB | 1 |
1 review(s) available for hydrazine and Vascular Diseases
| Article | Year |
|---|---|
[Adverse effects of important long-term-therapeutics].
Topics: Acidosis; Animals; Antidepressive Agents; Antitubercular Agents; Biguanides; Central Nervous System; Dehydration; Diabetes Mellitus; Diuretics; Dogs; Gout; Humans; Hydrazines; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Hypokalemia; Hyponatremia; Intestine, Small; Isoniazid; Potassium Chloride; Thiazines; Time Factors; Ulcer; Vascular Diseases | 1970 |
6 other study(ies) available for hydrazine and Vascular Diseases
| Article | Year |
|---|---|
Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity.
Topics: Angiotensin II; Animals; Cerebral Arteries; Humans; Hydrazines; Membrane Glycoproteins; Mice; Molecular Targeted Therapy; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitrogen Oxides; Oxidative Stress; Reactive Oxygen Species; Superoxides; Vascular Diseases | 2013 |
Thiamine deficiency leads to reduced nitric oxide production and vascular dysfunction in rats.
Topics: Acetylcholine; Animals; Aorta; Hydrazines; Indomethacin; Male; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Rats; Rats, Wistar; Thiamine Deficiency; Vascular Diseases; Vasoconstriction; Vasodilation | 2014 |
High arterial pressure as a primary cause of hypertensive vascular lesions.
Topics: Arterial Pressure; Arteries; Disease; Humans; Hydrazines; Hypertension; Vascular Diseases | 1959 |
Monoamine oxidase inhibitors and vascular disease.
Topics: Cardiovascular Diseases; Hydrazines; Monoamine Oxidase Inhibitors; Oxidoreductases; Vascular Diseases | 1960 |
Preliminary observations on the role of monoamine oxidase inhibitors in the therapy of peripheral arterial disease.
Topics: Hydrazines; Monoamine Oxidase Inhibitors; Oxidoreductases; Peripheral Arterial Disease; Peripheral Vascular Diseases; Vascular Diseases | 1960 |
Early vascular injury induced by 1,2-dimethylhydrazine dihydrochloride. II. Gross and electron microscopic findings.
Topics: Administration, Oral; Animals; Basement Membrane; Carcinogens; Hydrazines; Liver; Male; Mice; Microscopy, Electron; Time Factors; Vascular Diseases; Veins | 1972 |